Delaware Tech was awarded a $1 million grant in order to partner with Christiana Care’s Gene Editing Institute.
Read the full article at DelawareBusinessNow.com
The National Science Foundation (NSF) grant will support the development of a gene-editing curriculum for students at Christiana Care’s, Helen F. Graham Cancer Center & Research Institute.
Students will learn how to use leading-edge biomedical research tools that are transforming our understanding of human genetics and accelerating development of genetically based therapies for human diseases, including cancer, a release stated.
The Institute is a leader in personalized genetic medicine, unlocking the genetic mechanisms that drive cancer and that can lead to new therapies and pharmaceuticals to revolutionize cancer treatment, as well as providing instruction in the design and implementation of genetic tools. Gene editing in lung cancer research has already begun so that clinical trials can be initiated. The Gene Editing Institute is integrated into the Molecular Screening Facility at The Wistar Institute in Philadelphia.
Stay up-to-date on Everything Wilmington
Sign up for our Monthly Newsletter!